(Date:12/16/2009)... Dec. 16 Martek Biosciences Corporation (Nasdaq: ... fourth quarter and fiscal year ended October 31, 2009. ... 3% from $90.4 million in the fourth quarter of ... per diluted share, for the fourth quarter of fiscal ... $0.31 per diluted share, in last year,s fourth quarter. ...
(Date:12/16/2009)... Hahnemann among the Best in the Nation ... Hospital proudly announces it has been granted Magnet(R) ... Magnet Recognition Program(R). Magnet(R) is one of the ... center can achieve, and places Hahnemann among the ... have achieved this prestigious distinction. ,, At 9:00 ...
(Date:12/16/2009)... VEGAS, Dec. 16 Cord Blood America, ... blood stem cell preservation company ( http://www.cordblood-america.com ... of stem cells, a biological insurance policy, to ... has reduced its debt by a total of ... of 2009 and total debt eliminated for the ...
(Date:12/16/2009)... WALTHAM, Mass., Dec. 16 Decision Resources, ... firms for pharmaceutical and healthcare issues, finds that, ... Biotech/Janssen-Cilag,s Stelara and Abbott,s briakinumab (both interleukin inhibitors) ... in 2012 in the drug market for moderate ... will experience greater uptake, capturing nearly three times ...
Breaking Biology Technology:Martek Announces Fourth Quarter and FY 2009 Financial Results 2Martek Announces Fourth Quarter and FY 2009 Financial Results 3Martek Announces Fourth Quarter and FY 2009 Financial Results 4Martek Announces Fourth Quarter and FY 2009 Financial Results 5Martek Announces Fourth Quarter and FY 2009 Financial Results 6Martek Announces Fourth Quarter and FY 2009 Financial Results 7Martek Announces Fourth Quarter and FY 2009 Financial Results 8Martek Announces Fourth Quarter and FY 2009 Financial Results 9Martek Announces Fourth Quarter and FY 2009 Financial Results 10Martek Announces Fourth Quarter and FY 2009 Financial Results 11Martek Announces Fourth Quarter and FY 2009 Financial Results 12Martek Announces Fourth Quarter and FY 2009 Financial Results 13Martek Announces Fourth Quarter and FY 2009 Financial Results 14Hahnemann University Hospital Granted Magnet(R) Status 2Hahnemann University Hospital Granted Magnet(R) Status 3Cord Blood America Says 2009 Debt Reduction Tops $10 Million 2Cord Blood America Says 2009 Debt Reduction Tops $10 Million 3In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 2In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 3... S*BIO Pte Ltd, a cancer therapeutics,company, today announced ... led by Bio*One Capital and new investor Aravis ... Fund advised by,Adamant Biomedical Investments AG and Zurcher ... fund the development efforts of its,two lead compounds, ...
... SYDNEY, Australia, Oct. 19 /Xinhua-PRNewswire-FirstCall/ --,Pharmaceutical company ... it had received approval to market Aridol ... Aridol is indicated for measuring airway hyperresponsiveness ... countries - Denmark, Finland, France, Germany,Greece, Ireland, ...
... Mattel Children,s Hospital UCLA today announced the launch ... explore the future of personalized medicine for children, ... is one of the world,s first dedicated solely ... , "Why develop a nanopediatrics program? Because children ...
Other Biology Technology:S*BIO Completes US$26 Million Equity Financing 2S*BIO Completes US$26 Million Equity Financing 3S*BIO Completes US$26 Million Equity Financing 4Pharmaxis Aridol Approved for Sale in Switzerland 2Mattel Children's Hospital UCLA launches program in nanopediatrics 2Request Info...
Request Info...
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Fast, sensitive quantitation of Mouse IgM concentration....
Biology Products:Biology NavigationMedical Navigation